Connect with us
DAPA Banner

Crypto World

UnitedHealth (UNH) Stock Faces Pressure from Analyst Downgrades and Regulatory Challenges

Published

on

UnitedHealth Group Incorporated (UNH)

Key Takeaways

  • Shares began trading at $277.32, significantly below the 52-week peak of $606.36
  • Wall Street firms reduced price targets — JPMorgan to $389, Truist to $370, UBS to $410
  • Weiss Ratings issued a Sell recommendation in early March
  • Fourth-quarter EPS of $2.11 slightly exceeded forecasts; revenue climbed 12.3% to $113.73 billion
  • Consensus rating stays at Moderate Buy with a $372.13 mean target according to MarketBeat

UnitedHealth Group (UNH) has experienced significant turbulence recently. Shares opened Monday’s session at $277.32, trading considerably beneath both the 50-day moving average of $297.19 and the 200-day moving average of $324.39.

UnitedHealth Group Incorporated (UNH)
UnitedHealth Group Incorporated (UNH)

This marks a substantial decline from the 52-week peak of $606.36. The stock’s 52-week bottom rests at $234.60.

The healthcare giant’s market capitalization presently registers at $251.71 billion, accompanied by a price-to-earnings multiple of 21.02 and a beta of 0.41.

The company maintains a debt-to-equity ratio of 0.72, while both current and quick ratios stand at 0.79.

During January, UnitedHealth disclosed fourth-quarter earnings of $2.11 per share, marginally surpassing the consensus forecast of $2.09. Revenue totaled $113.73 billion, representing a 12.3% year-over-year increase and slightly exceeding Wall Street projections.

However, the Q4 EPS figure represents a significant decline compared to the $6.81 posted during the corresponding quarter last year.

Advertisement

Wall Street Firms Reduce Price Targets

Multiple prominent investment banks have decreased their price objectives in recent weeks.

JPMorgan reduced its target from $425 down to $389, Morgan Stanley adjusted downward from $411 to $409, and UBS lowered its projection from $430 to $410. Truist executed the most aggressive reduction, dropping from $410 to $370. Despite these cuts, all four firms preserved Buy or Overweight recommendations.

Weiss Ratings took a more bearish stance, downgrading UNH from Hold to Sell during early March.

According to MarketBeat, the current consensus rating remains at Moderate Buy, featuring 17 Buy recommendations, 8 Hold ratings, and 2 Sell ratings. The mean 12-month price objective stands at $372.13 — suggesting approximately 34% potential upside from present levels.

Advertisement

Regarding institutional investors, significant movements have occurred. Wealth Enhancement Advisory Services reduced its position by 40.6% during Q4, liquidating 170,643 shares. Conversely, Norges Bank, Berkshire Hathaway, and Capital Research Global Investors all increased or established new positions throughout 2024. Institutional investors collectively control 87.86% of outstanding shares.

Ongoing Regulatory Concerns

Department of Justice investigations concerning Medicare Advantage reimbursement methodologies continue creating headwinds for investor sentiment. While the company has secured at least one favorable legal outcome in that matter, broader regulatory pressures surrounding prior-authorization procedures and coverage denial practices persist.

Executives have previously disclosed intentions to reduce certain Medicare Advantage membership and adjust product pricing in response to changing cost dynamics.

Management provided fiscal year 2026 EPS guidance of approximately $17.75. Wall Street analysts currently project full-year EPS of $29.54 for the ongoing fiscal year.

Advertisement

UNH distributed a quarterly dividend of $2.21 per share on March 17, translating to an annualized yield of approximately 3.2%. The current payout ratio stands at 67.02%.

On a constructive note, UnitedHealth recently unveiled a nationwide expansion of its doula benefit initiative, which may enhance member retention and drive improved outcomes within its value-based care framework.

Source link

Advertisement
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Crypto World

Bitcoin Set To Sync With Stocks, Possibly Chasing New Range Highs

Published

on

Bitcoin Set To Sync With Stocks, Possibly Chasing New Range Highs

Bitcoin (BTC) treaded water at Thursday’s Wall Street open as the S&P 500 reached new all-time highs.

Key points:

  • Bitcoin stays locked on $74,000 after its local highs preceded a new record for the S&P 500.

  • Analysis warns that the US midterm elections may impact the stock rally.

  • Bitcoin could follow the Nasdaq 100 higher, a trader suggests.

BTC price tripped after fresh highs from the S&P 500

Data from TradingView showed $74,000 continuing to form an intraday BTC price focus.

BTC/USD one-hour chart. Source: Cointelegraph/TradingView

US jobless claims came in marginally below expectations at 207,000 versus 213,000, pointing to the labor market withstanding current geopolitical and inflation pressures.

These followed a new record for the S&P 500, which crossed 7,000 points for the first time in history after Bitcoin hit two-month highs.

Advertisement

Commenting, trading resource Mosaic Asset Company noted that the S&P had advanced by nearly 11% in the past 11 trading sessions.

“It ranks as the fifth quickest recovery to record highs following a deep pullback,” it wrote in its latest “Mosaic Chart Alerts” update. 

“The S&P closed firmly above the 7,000 level for the first time in history despite the ongoing uncertainty in the Middle East that sparked a 9% drawdown in the index into late March.”

S&P 500 one-day chart. Source: Cointelegraph/TradingView

Gold dipped to intraday lows and WTI crude oil eyed $94 per barrel as markets awaited further cues over the US-Iran war.

QCP, meanwhile, warned that seasonal trends could still end the stock rally as the US entered midterm elections. The S&P 500, it noted, “tends to find its peak about now ahead of mid-term elections, and then recovering during the final quarter of the year.”

“I would not base any investment decision or outlook based on seasonals alone, which is why I’m also watching confirmation from breadth,” it cautioned.

Advertisement
S&P 500 seasonality data. Source: Mosaic Asset Company

Trader sees “opportunity” in Bitcoin versus Nasdaq

With BTC price action finding resistance near its range highs, market participants eyed exchange order-book liquidity for clues as to where the next showdown could come.

Related: Bitcoin can grow ‘probably a lot bigger’ than $30T+ gold market — Analysis

“The price bucket at $72.2K – 72.4K has a large amount of open interest that has slowly accumulated,” Shubh Varma, CEO of crypto data platform Hyblock, told Cointelegraph on the day.

“We’ve seen this level where traders are often active, entering and exiting. Most recently, about $100 million longs and shorts opened here, bringing the total close to $400 million at that price bucket, over the last seven days (on Binance stablecoin perps).”

Varma added that this could form “an area to watch as potential support if price revisits it, as many of these longs and shorts may exit at breakeven ‘psychological’ level.”

BTC/USDT perpetual contract open interest data. Source: Hyblock

Continuing the stocks theme, crypto trader Michaël van de Poppe flagged Bitcoin’s relationship with the Nasdaq-100 index as a cause for optimism going forward.

“Bitcoin is about to follow Nasdaq,” he told X followers. 

Advertisement

“The reason for this is quite simple: the correlation has been significantly strong most of the time. This period? The weakest correlation in the past 10 years.”

BTC/USD vs. Nasdaq 100 futures one-week chart. Source: Michaël van de Poppe/X

Van de Poppe eyed a “tremendous opportunity” for Bitcoin buyers, having recently seen a similar bullish setup in Bitcoin versus gold.